Clinical Trial Update: Somatuline Autogel Preference and Health Economy Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on Somatuline Autogel preference and health economy study in neuroendocrine tumor with carcinoid symptoms; completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor with Carcinoid Symptoms

Drugs mentioned

• Somatuline Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Neuroendocrine Tumour With Carcinoid Symptoms | Phase 4 | Status: COMPLETED | Results posted: 2012-03-13